Advertisement
Singapore markets closed
  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     
  • S&P 500

    5,063.29
    -7.26 (-0.14%)
     
  • Dow

    38,369.18
    -134.51 (-0.35%)
     
  • Nasdaq

    15,722.04
    +25.40 (+0.16%)
     
  • Bitcoin USD

    64,775.76
    -1,992.54 (-2.98%)
     
  • CMC Crypto 200

    1,406.35
    -17.75 (-1.25%)
     
  • FTSE 100

    8,039.47
    -5.34 (-0.07%)
     
  • Gold

    2,345.20
    +3.10 (+0.13%)
     
  • Crude Oil

    82.96
    -0.40 (-0.48%)
     
  • 10-Yr Bond

    4.6500
    +0.0520 (+1.13%)
     
  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     
  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     
  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     
  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     
  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Australia watchdog appeals fine on Reckitt Benckiser as too light

Nurofen pain relievers targeting specific types of pain are seen on a pharmacy shelf in Sydney, Australia December 14, 2015. REUTERS/Jason Reed

MELBOURNE (Reuters) - Australia's competition watchdog on Monday filed an appeal against the A$1.7 million ($1.2 million) fine a court ordered British consumer goods giant Reckitt Benckiser (RB.L) pay for misleading consumers on painkiller marketing.

"The ACCC will submit to the Full Court of the Federal Court that A$1.7 million in penalties imposed on a company the size of Reckitt Benckiser does not act as an adequate deterrent and might be viewed as simply a cost of doing business," Australia Competition and Consumer Commission Chairman Rod Sims said in a statement.

The commission said earlier in May a penalty of at least A$6 million would have been appropriate.

($1 = 1.3841 Australian dollars)

(Reporting by Sonali Paul; Editing by Stephen Coates)